Ofirmev

Cadence Pharmaceuticals: Ofirmev Launch Is Strong; Resolution Of Patent Issues Could Be Soon

Cadence Pharmaceuticals: Ofirmev Launch Is Strong; Resolution Of Patent Issues Could Be Soon

Seeking Alpha

Cadence Forecasts Ofirmev Sales

Cadence Forecasts Ofirmev Sales

Yahoo/Zacks

Cadence Pharmaceuticals Investor/Analyst Day Highlights Strong Ofirmev Growth Trends

Cadence Pharmaceuticals Investor/Analyst Day Highlights Strong Ofirmev Growth Trends

Seeking Alpha

Cadence Pharmaceuticals' Ofirmev Launch Has Gained Traction: Buy

Cadence Pharmaceuticals' Ofirmev Launch Has Gained Traction: Buy

Seeking Alpha

Cadence Pharma falls to life-low on disappointing results

Cadence Pharma falls to life-low on disappointing results

Reuters

Cadence's Ofirmev Launch Is Gaining Traction

Cadence's Ofirmev Launch Is Gaining Traction

Seeking Alpha

3 Ways to Participate in Cadence Pharmaceuticals' Breakout

3 Ways to Participate in Cadence Pharmaceuticals' Breakout

Seeking Alpha

News

Cadence Pharmaceuticals: A Rising Star

Seeking Alpha

News

Cadence Pharmaceuticals Needs Fast-Paced Ofirmev Launch to Build Confidence

Seeking Alpha

News

Cadence Pharma starts selling IV pain drug Ofirmev

Yahoo/AP